Abstract
Ependymoma management remains challenging because of the inherent chemoresistance of this tumor. To determine whether ependymoma stem cells (SCs) might contribute to therapy resistance, we investigated the sensitivity of ependymoma SCs to temozolomide and etoposide.
Lingua originale | English |
---|---|
pagine (da-a) | N/A-N/A |
Rivista | Neuro-Oncology |
DOI | |
Stato di pubblicazione | Pubblicato - 2014 |
Keywords
- MGMT
- differentiation
- ependymoma stem cells
- orthotopic models
- temozolomide